Finally, our in vitro experiments demonstrated that silencing WASF2 inhibited the proliferation, migration, and invasiveness of ovarian cancer cells, and confirmed that WASF2 were highly expressed in ovarian cancer by immunohistochemistry. Here, WASF2 is linked to ovarian carcinoma.